Clinical Trial Update: DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission [Phase 2]

View source ↗

Summary

This clinical trial update outlines a Phase 2 study evaluating a DC/AML fusion cell vaccine versus observation in AML patients who achieved remission after chem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• DC/AML Fusion Cell Vaccine

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Acute Myelogenous Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING